Disruptions in effort-based decision-making and consummatory behavior following antagonism of the dopamine D2 receptor
Related Experiment Video
Updated: Mar 10, 2026

Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
Cindee F Robles1, Alexander W Johnson1
1Department of Psychology and Neuroscience Program, Michigan State University, East Lansing, MI 48824, United States.
Abstract:
Dopamine is known to influence motivational processes, however the precise role of this neurotransmitter remains a contentious issue. In the current study we sought to further characterize dopamine signaling in reward-based decision-making and consummatory behavior in mice, via lateral ventricle infusion of the dopamine D2 receptor antagonist eticlopride. In Experiment 1, we examined effort-based decision-making, in which mice had a choice between one lever, where a single response led to the delivery of a low value reward (2% sucrose); and a second lever, which led to a higher value reward (20% sucrose) that gradually required more effort to obtain. As the response schedule for the high value reward became more strict, low dose (4μg in 0.5μl) central infusions of eticlopride biased preference away from the high value reward, and toward the lever that led to the low value reward. Similarly, a higher dose of eticlopride (8μg in 0.5μl) also disrupted choice responding for the high value reward, however it did so by increasing omissions. In Experiment 2, we assessed the effects of eticlopride on consumption of 20% sucrose. The antagonist led to a dose-dependent reduction in intake, and through an analysis of licking microstructure, it was revealed that this in part reflected a reduction in the motivation to engage in consummatory behavior, rather than alterations in the evaluation of the reward. These results suggest that disruptions in D2 receptor signaling reduce the willingness to engage in effortful operant responding and consumption of a desirable outcome.
Insights
Blocking dopamine D2 receptors with eticlopride reduced mice's motivation for rewards. This neurotransmitter impacts effort-based decisions and consumption, highlighting its role in reward-seeking behaviors.
Area of Science:
- Neuroscience
- Behavioral Science
- Pharmacology
Background:
- Dopamine is implicated in motivation, but its exact function in decision-making and consumption is debated.
- Dopamine D2 receptors are key targets for understanding these motivational processes.
Purpose of the Study:
- To investigate the role of dopamine D2 receptor signaling in effort-based decision-making and reward consumption.
- To characterize how eticlopride, a D2 receptor antagonist, affects motivated behaviors in mice.
Main Methods:
- Mice were infused centrally with eticlopride (a dopamine D2 receptor antagonist) at varying doses.
- Effort-based decision-making was assessed using a two-lever choice task with different sucrose reward values and response requirements.
- Consummatory behavior was measured by intake of sucrose solution, with licking microstructure analyzed.
Main Results:
- Eticlopride administration biased choice away from high-value rewards and towards low-value rewards as effort increased.
- Higher eticlopride doses increased response omissions for high-value rewards.
- Eticlopride dose-dependently reduced sucrose intake, primarily by decreasing motivation to consume, not reward evaluation.
Conclusions:
- Disrupting dopamine D2 receptor signaling diminishes the motivation for effortful operant responding and consumption of desirable outcomes.
- These findings underscore the critical role of D2 receptor pathways in regulating motivated behaviors and reward processing.
More Related Videos
07:42An Automated T-maze Based Apparatus and Protocol for Analyzing Delay- and Effort-based Decision Making in Free Moving Rodents
Published on: August 2, 2018
13:20Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance
Published on: December 5, 2025
Related Concept Videos
Drugs Affecting Neurotransmitter Synthesis
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Drugs Affecting Neurotransmitter Release or Uptake
Desensitization and Tachyphylaxis
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...